Provided by Tiger Fintech (Singapore) Pte. Ltd.

Poseida Therapeutics, Inc.

9.50
0.0000
Volume:- -
Turnover:203.93M
Market Cap:928.85M
PE:-14.95
High:9.50
Open:9.50
Low:9.50
Close:9.50
Loading ...

Poseida Therapeutics Acquisition Set to Be Completed, Roche Says

MT Newswires Live
·
08 Jan

Deals of the day-Mergers and acquisitions

Reuters
·
08 Jan

Roche Finalizes Tender Offer for $1.5B Poseida Deal

TIPRANKS
·
08 Jan

LIVE MARKETS-Europe before the bell: futures falter as Trump, jobs data in focus

Reuters
·
08 Jan

Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida

Reuters
·
08 Jan

BRIEF-Roche Purchases Shares Of Poseida Therapeutics, Inc. In Tender Offer

Reuters
·
08 Jan

Poseida Therapeutics, Inc. (PSTX) Hits Fresh High: Is There Still Room to Run?

Zacks
·
13 Dec 2024

Poseida Therapeutics Says New Data Support Potential of Allogeneic Cell Therapy Platform

MT Newswires Live
·
10 Dec 2024

Poseida Therapeutics highlights interim Phase 1 results for P-BCMA-ALLO1

TIPRANKS
·
10 Dec 2024

Poseida Therapeutics Highlights Positive Interim Phase 1 Results for P-BCMA-ALLO1 and Preclinical Data for Dual CAR-T P-CD19CD20-ALLO1 at the 66th American Society of Hematology (ASH) Annual Meeting

PR Newswire
·
10 Dec 2024

PBF Energy, Poseida Therapeutics, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
07 Dec 2024

The Zacks Analyst Blog Highlights Roche, Poseida Therapeutics, Merck, AstraZeneca and Novartis

Zacks
·
02 Dec 2024

Poseida Therapeutics Inc : Piper Sandler Cuts to Neutral From Overweight

THOMSON REUTERS
·
02 Dec 2024

Pharma Stock Roundup: RHHBY to Buy PSTX, MRK, AZN See Pipeline Success

Zacks
·
30 Nov 2024

Should You Buy Poseida Therapeutics, Inc. (PSTX) After Golden Cross?

Zacks
·
28 Nov 2024

Poseida Therapeutics, Inc. (PSTX) Hit a 52 Week High, Can the Run Continue?

Zacks
·
27 Nov 2024

Stock Track | Poseida Therapeutics Soars 6.61% on $1.5B Acquisition Deal with Roche Holdings

Stock Track
·
27 Nov 2024

Poseida Therapeutics (NASDAQ:PSTX) Stock Skyrockets on News of Roche Holdings Acquisition

TIPRANKS
·
27 Nov 2024

Poseida Therapeutics Cut to Market Perform From Outperform by William Blair

Dow Jones
·
27 Nov 2024

Why This Gene-Therapy Company's Stock Is Rising 228% -- Barrons.com

Dow Jones
·
27 Nov 2024